Identifying the facilitators and barriers to implementation of renal tumour biopsy in the diagnostic pathway for small renal masses

IF 3.7 2区 医学 Q1 UROLOGY & NEPHROLOGY BJU International Pub Date : 2024-07-23 DOI:10.1111/bju.16470
Veronica Ranieri, Hannah Warren, Isabella Florez, Joana B. Neves, Miles Walkden, Darryl E. Bernstein, Joseph Santiapillai, Norman Williams, William H. Wildgoose, Prasad Patki, Grant D. Stewart, Netty Kinsella, Elena Pizzo, Ravi Barod, Axel Bex, Faiz Mumtaz, Soha El-Sheikh, Kurinchi Gurusamy, Maxine G.B. Tran
{"title":"Identifying the facilitators and barriers to implementation of renal tumour biopsy in the diagnostic pathway for small renal masses","authors":"Veronica Ranieri,&nbsp;Hannah Warren,&nbsp;Isabella Florez,&nbsp;Joana B. Neves,&nbsp;Miles Walkden,&nbsp;Darryl E. Bernstein,&nbsp;Joseph Santiapillai,&nbsp;Norman Williams,&nbsp;William H. Wildgoose,&nbsp;Prasad Patki,&nbsp;Grant D. Stewart,&nbsp;Netty Kinsella,&nbsp;Elena Pizzo,&nbsp;Ravi Barod,&nbsp;Axel Bex,&nbsp;Faiz Mumtaz,&nbsp;Soha El-Sheikh,&nbsp;Kurinchi Gurusamy,&nbsp;Maxine G.B. Tran","doi":"10.1111/bju.16470","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Objectives</h3>\n \n <p>To understand the facilitators and barriers to the implementation of renal tumour biopsy (RTB) in the diagnostic pathway for renal tumours in England.</p>\n </section>\n \n <section>\n \n <h3> Patients and Methods</h3>\n \n <p>Participants consisted of patients who had a renal tumour diagnosed and/or treated at one of five tertiary centres in England, healthcare professionals involved in the direct care of patients diagnosed with renal tumours, and clinical service managers and commissioners. The study employed a mixed-methods research methodology consisting of individual interviews and an on-line survey that explored the types of facilitators and barriers individuals perceived and experienced and the frequency in which these were reported. A public dissemination event took place following the completion of data collection; to facilitate discussion of potential solutions to implementing RTB.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>There were 50 participant interviews (23 patients, 22 clinicians, and five health service commissioners/operations managers). The patient on-line survey received 52 responses, and the clinician survey received 22 responses. Patients most frequently reported influences in choosing whether to undergo RTB pertained to wanting to know the diagnosis of their kidney mass (40%), the advice or information provided by healthcare professionals (40%), and not wishing to delay treatment (23%). Clinicians most frequently reported barriers to recommending RTB related to their uncertainty of diagnostic accuracy (56%), availability of appointments or hospital beds (52%), concerns of risk of bleeding (44%), risk of seeding (41%), and delays in meeting national cancer pathway targets (41%). The dissemination event was attended by 18 participants (seven patients and 11 clinicians). Suggestions to improve implementation included reducing variation and promotion of standardisation of practice by a consensus statement, increasing the evidence base (clinicians) and improved communication by developing better patient aids such as videos and diagrams (patients and clinicians).</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Implementation of RTB may be dependent on the quality of information provided, its format and perceived reliability of the information. Increased utilisation of RTB may be improved by development of a consensus statement on the role of biopsy, with patients expressing a preference for alternative information aids such as patient videos.</p>\n </section>\n </div>","PeriodicalId":8985,"journal":{"name":"BJU International","volume":null,"pages":null},"PeriodicalIF":3.7000,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bju.16470","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJU International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bju.16470","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives

To understand the facilitators and barriers to the implementation of renal tumour biopsy (RTB) in the diagnostic pathway for renal tumours in England.

Patients and Methods

Participants consisted of patients who had a renal tumour diagnosed and/or treated at one of five tertiary centres in England, healthcare professionals involved in the direct care of patients diagnosed with renal tumours, and clinical service managers and commissioners. The study employed a mixed-methods research methodology consisting of individual interviews and an on-line survey that explored the types of facilitators and barriers individuals perceived and experienced and the frequency in which these were reported. A public dissemination event took place following the completion of data collection; to facilitate discussion of potential solutions to implementing RTB.

Results

There were 50 participant interviews (23 patients, 22 clinicians, and five health service commissioners/operations managers). The patient on-line survey received 52 responses, and the clinician survey received 22 responses. Patients most frequently reported influences in choosing whether to undergo RTB pertained to wanting to know the diagnosis of their kidney mass (40%), the advice or information provided by healthcare professionals (40%), and not wishing to delay treatment (23%). Clinicians most frequently reported barriers to recommending RTB related to their uncertainty of diagnostic accuracy (56%), availability of appointments or hospital beds (52%), concerns of risk of bleeding (44%), risk of seeding (41%), and delays in meeting national cancer pathway targets (41%). The dissemination event was attended by 18 participants (seven patients and 11 clinicians). Suggestions to improve implementation included reducing variation and promotion of standardisation of practice by a consensus statement, increasing the evidence base (clinicians) and improved communication by developing better patient aids such as videos and diagrams (patients and clinicians).

Conclusion

Implementation of RTB may be dependent on the quality of information provided, its format and perceived reliability of the information. Increased utilisation of RTB may be improved by development of a consensus statement on the role of biopsy, with patients expressing a preference for alternative information aids such as patient videos.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
确定在肾脏小肿块诊断路径中实施肾脏肿瘤活检的促进因素和障碍。
目的了解在英格兰肾肿瘤诊断路径中实施肾肿瘤活检(RTB)的促进因素和障碍:参与者包括在英格兰五个三级中心之一接受肾肿瘤诊断和/或治疗的患者、参与直接护理肾肿瘤患者的医护人员以及临床服务管理人员和专员。该研究采用了混合研究方法,包括个人访谈和在线调查,以探讨个人认为和经历的促进因素和障碍类型,以及报告这些因素和障碍的频率。数据收集工作完成后举行了一次公开宣传活动,以促进对实施 RTB 潜在解决方案的讨论:共进行了 50 次访谈(23 名患者、22 名临床医生和 5 名医疗服务专员/业务经理)。患者在线调查收到了 52 份回复,临床医生调查收到了 22 份回复。患者在选择是否接受 RTB 治疗时最常提到的影响因素包括:想知道肾脏肿块的诊断结果(40%)、医护人员提供的建议或信息(40%)以及不想延误治疗(23%)。临床医生最常报告的推荐 RTB 的障碍涉及诊断准确性的不确定性(56%)、预约或医院床位的可用性(52%)、出血风险的担忧(44%)、播种风险(41%)以及实现国家癌症路径目标的延迟(41%)。有 18 人(7 名患者和 11 名临床医生)参加了宣传活动。改善实施情况的建议包括:通过共识声明减少差异和促进实践标准化、增加证据基础(临床医生)以及通过开发更好的患者辅助工具(如视频和图表)改善沟通(患者和临床医生):RTB 的实施可能取决于所提供信息的质量、格式以及对信息可靠性的认知。通过就活检的作用制定共识声明可提高 RTB 的使用率,而患者则表示更倾向于使用其他信息辅助工具,如患者视频。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BJU International
BJU International 医学-泌尿学与肾脏学
CiteScore
9.10
自引率
4.40%
发文量
262
审稿时长
1 months
期刊介绍: BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.
期刊最新文献
A luminal non-coding RNA-based genomic classifier confirms favourable outcomes in patients with clinically organ-confined bladder cancer treated with radical cystectomy. Unravelling the evolution of medical scientific publishing to hold the promise of science for better patient care. An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial Mortality rates in radical cystectomy patients with bladder cancer after radiation therapy for prostate cancer. Cumulative re‐operation rates during follow‐up after hypospadias repair
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1